drugset / Trial / NCT02394132
Radiotherapy or Imiquimod in Complex Lentigo Maligna
Phase 3
Completed
126 enrolled
Melanoma and Skin Cancer Trials Limited
Melanoma Institute Australia · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the effectiveness of using either radiotherapy (RT) or Imiquimod (ImiQ) to treat the Lentigo Maligna (LM), when surgery is not possible, is refused, or fails.
Timeline
- Start
- 2015-08-31
- Primary completion
- 2021-12-24
- Completion
- 2023-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imiquimod | Other / unclassified | 5 % | Topical |